NCR3 and neoplasm: Our data indicate that NKp30+CD8+ T cells can be exploited for their anti-tumor activity, that combines both recognition capabilities of CD8+ T cells and NK cells, broadening the spectrum of tumor cells recognized and eliminated by adoptively transferred effector cells.